| PERIOD ENDING | 12-Sep-09 | 20-Jun-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 9,461,000 | 12,715,000 | 10,820,000 | 10,171,000 | | Cost of Revenue | 7,372,000 | 9,868,000 | 8,341,000 | 7,891,000 | | | Gross Profit | 2,089,000 | 2,847,000 | 2,479,000 | 2,280,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,844,000 | 2,485,000 | 2,269,000 | 1,921,000 | | Non Recurring |
-
|
-
| 274,000 | 3,250,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 245,000 | 362,000 | (64,000) | (2,891,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 11,000 |
-
| | Earnings Before Interest And Taxes | 245,000 | 362,000 | (53,000) | (2,891,000) | | Interest Expense | 131,000 | 177,000 | 159,000 | 143,000 | | Income Before Tax | 114,000 | 185,000 | (212,000) | (3,034,000) | | Income Tax Expense | 40,000 | 72,000 | (11,000) | (90,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 74,000 | 113,000 | (201,000) | (2,944,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 74,000 | 113,000 | (201,000) | (2,944,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $74,000 | $113,000 | ($201,000) | ($2,944,000) |
|
0.16% Nasdaq 
0.04%
Income Statement
